Since Rac1 hyperactivation in cancer cells frequently correlates with elevated expression and/or activation of Rac1-GEFs [13], we speculated that the ∆Np63α-mediated reduction of Rac1 activity could be associated with a reduction in the levels of upstream Rac-GEFs. The gene discussed is RAC1; the disease is cancer.